Long-term methylphenidate treatment down-regulates c-fos in the striatum of male CD-1 mice

Area of Science:

• Neuroscience
• Developmental Psychology
• Pharmacology

Background:

• Methylphenidate (MPH), commonly known as Ritalin, is widely prescribed for attention deficit hyperactivity disorder (ADHD) in children.
• The long-term effects of MPH on brain development remain largely unknown.
• Understanding MPH's impact on neural activity during critical developmental periods is crucial.

Purpose of the Study:

• To investigate the long-term consequences of methylphenidate hydrochloride (MPH) on brain development in pre- and peri-pubertal male mice.
• To quantify the expression of the immediate early gene c-fos in the striatum following MPH treatment.
• To assess how repeated MPH exposure affects neural responses to subsequent doses.

Main Methods:

• Pre- and peri-pubertal male CD-1 mice were administered repeated injections of methylphenidate hydrochloride (MPH).
• The expression of the immediate early gene c-fos was quantified in the striatum.
• FOS immunoreactivity was measured after single and repeated MPH administrations (5 or 40 mg/kg) compared to saline controls.

Main Results:

• A single MPH injection significantly increased FOS immunoreactivity in the striatum in a dose-dependent manner.
• Repeated MPH treatment led to an attenuated response to a subsequent challenge dose of MPH.
• These findings indicate a down-regulation of gene expression in the striatum following long-term MPH use.

Conclusions:

• Long-term methylphenidate use in developing male mice may alter neural activity.
• Repeated MPH exposure appears to down-regulate gene expression, specifically c-fos, in the striatum.
• These results suggest potential modifications in neural pathways due to chronic MPH administration during critical developmental stages.